July 31, 2014 6:06 AM ET

Biotechnology

Company Overview of Kirax Corporation

Company Overview

Kirax Corporation, a biopharmaceutical company, engages in acquiring, developing, and commercializing specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. Its product pipeline includes AFP-464, an anti-cancer agent in patients with breast cancer; GGTI-2418, a synthetic peptidomimetic inhibitor of geranylgeranyltransferase I (GGTase I) that appears to induce apoptosis by down-regulating several pivotal oncogenic and tumor survival pathways; and GFB-204, a calixarene derivative that is an inhibitor of VEGFR and PDGFR tyrosine phosphorylation. The company licenses or acquires rights to compounds in various stages of clinical dev...

3359 Woods Edge Circle

Suite 103

Bonita Springs, FL 34134

United States

Founded in 2005

Phone:

239-444-5400

Fax:

321-206-8627

Key Executives for Kirax Corporation

Chief Executive Officer
Executive Chairman
Age: 70
Co Founder
Age: 37
Chief Medical Officer and Vice President of Clinical Development
Age: 55
Chief Medical Officer
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Synlogic, Inc. United States
ViaCell, Inc. United States
SouthernBiotech United States
Nano3D Biosciences, Inc. United States
Vascular Strategies LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Kirax Corporation, please visit www.kiraxcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.